Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease.

April 10, 2024 updated by: Tiago Ribeiro Amaral, Universitat Internacional de Catalunya

Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease. A Multi-center Cross-sectional Study

The aim of this study is to analyse contiguous dental implants and its peri-implant status depending on different inter-implant distances.

Study Overview

Detailed Description

The present research project has been designed as a multicentric cross-sectional study. The STROBE guidelines have been followed in the design of this observational study.

Ethical issues The study will be performed after the approval of the Ethics Committee of the Universitat Internacional de Catalunya (UIC) and Faculdade de Medicina Dentária da Universidade de Lisboa (FMDUL) and will be intended to be registered in clinicaltrials.gov. Also, this research will be conducted according to the principles outlined in the Declaration of Helsinki (revised, amended, and clarified in 2013). In addition, all study participants will provide written informed consent before participating in the study.

Study population Subjects will be selected from an electronic database collected at the CUO (UIC) / CU (FMDUL) and composed of patients treated with at least two contiguous dental implants before 2021. This investigation will use a stratified random sampling based on year of implant placement to select a representative sample of subjects with implant-supported restorations conducted during the period 2001-2020 at the CUO and CU. Then, two examiners (I.T. / F.F.) will contact patients by telephone once every 2 days (with a maximum of 3 attempts) for an evaluation by the same investigators (I.T / F.F).

Criteria for subject selection will be as follows:

  • The patient must be ≥18 years of age and systemically healthy;
  • Partially edentulous patients, rehabilitated until 2020 (i.e., a minimum of 3 years of function time) with at least two contiguous implant-supported restorations in the maxilla or mandible;
  • Screw or cemented-retained prosthesis;
  • Fixed dental prosthesis (i.e., single crowns and partial prosthesis);
  • No implant mobility.

Moreover, the exclusion criteria will be the following:

  • Pregnant and lactating women;
  • Patients who have taken systemic antibiotics during the 3 months prior to the examination;
  • Patients being treated with drugs that may induce a gingival overgrowth;
  • Patients undergoing orthodontic treatment (since it can influence periodontal diagnosis);
  • Patients who have received mechanical debridement during the 3 months prior to the exam;
  • Patients who have received surgical treatment for peri-implantitis;
  • Psychophysical inability to carry out study procedures.

Study Type

Observational

Enrollment (Estimated)

180

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Barcelona
      • Sant Cugat Del Vallès, Barcelona, Spain, 08195
        • Clínica Universitaria de Odontologia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Subjects will be selected from an electronic database collected at the CUO (UIC) / CU (FMDUL) and composed of patients treated with at least two contiguous dental implants before 2021. This investigation will use a stratified random sampling based on year of implant placement to select a representative sample of subjects with implant-supported restorations conducted during the period 2001-2020 at the CUO and CU. Then, two examiners (I.T. / F.F.) will contact patients by telephone once every 2 days (with a maximum of 3 attempts) for an evaluation by the same investigators (I.T / F.F).

Description

Inclusion Criteria:

  • The patient must be ≥18 years of age and systemically healthy;
  • Partially edentulous patients, rehabilitated until 2020 (i.e., a minimum of 3 years of function time) with at least two contiguous implant-supported restorations in the maxilla or mandible;
  • Screw or cemented-retained prosthesis;
  • Fixed dental prosthesis (i.e., single crowns and partial prosthesis);
  • No implant mobility.

Exclusion Criteria:

  • Pregnant and lactating women;
  • Patients who have taken systemic antibiotics during the 3 months prior to the examination;
  • Patients being treated with drugs that may induce a gingival overgrowth;
  • Patients undergoing orthodontic treatment (since it can influence periodontal diagnosis);
  • Patients who have received mechanical debridement during the 3 months prior to the exam;
  • Patients who have received surgical treatment for peri-implantitis;
  • Psychophysical inability to carry out study procedures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Inter-implant distance ≤ 3mm
Presence of an inter-implant distance ≤ 3mm
Implant Placement of 2 contiguous dental implants with less ≤ 3mm from each other.
Inter-implant distance ≥ 3mm
Presence of an inter-implant distance ≥ 3mm
Implant Placement of 2 contiguous dental implants with > 3mm from each other.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of peri-implant diseases.
Time Frame: At least 36 months of function - at the moment of the evaluation
Prevalence of peri-implant mucositis and peri-implantitis.
At least 36 months of function - at the moment of the evaluation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FMPI
Time Frame: At least 36 months of function - at the moment of the evaluation
Full Mouth Plaque Index
At least 36 months of function - at the moment of the evaluation
FMBI
Time Frame: At least 36 months of function - at the moment of the evaluation
Full Mouth Bleeding Index
At least 36 months of function - at the moment of the evaluation
mPI
Time Frame: At least 36 months of function - at the moment of the evaluation
modified Plaque Index
At least 36 months of function - at the moment of the evaluation
mBI
Time Frame: At least 36 months of function - at the moment of the evaluation
modified Bleeding Index
At least 36 months of function - at the moment of the evaluation
SoP
Time Frame: At least 36 months of function - at the moment of the evaluation
Suppuration on Probing
At least 36 months of function - at the moment of the evaluation
PPD
Time Frame: At least 36 months of function - at the moment of the evaluation
Probing Pocket Depth
At least 36 months of function - at the moment of the evaluation
MR
Time Frame: At least 36 months of function - at the moment of the evaluation
Mucosal Recession
At least 36 months of function - at the moment of the evaluation
KM
Time Frame: At least 36 months of function - at the moment of the evaluation
Keratinized Mucosa
At least 36 months of function - at the moment of the evaluation
Implant location
Time Frame: At least 36 months of function - at the moment of the evaluation
Implant location in the oral cavity
At least 36 months of function - at the moment of the evaluation
Implant position
Time Frame: At least 36 months of function - at the moment of the evaluation
Implant position in the oral cavity
At least 36 months of function - at the moment of the evaluation
Implant type
Time Frame: At least 36 months of function - at the moment of the evaluation
Implant type used
At least 36 months of function - at the moment of the evaluation
Implant brand
Time Frame: At least 36 months of function - at the moment of the evaluation
Brand of the implant used
At least 36 months of function - at the moment of the evaluation
Implant roughness
Time Frame: At least 36 months of function - at the moment of the evaluation
Type of implant roughness
At least 36 months of function - at the moment of the evaluation
Implant diameter
Time Frame: At least 36 months of function - at the moment of the evaluation
Type of implant diameter
At least 36 months of function - at the moment of the evaluation
Implant length
Time Frame: At least 36 months of function - at the moment of the evaluation
Length of the implant
At least 36 months of function - at the moment of the evaluation
Apico-coronal position of the implant
Time Frame: At least 36 months of function - at the moment of the evaluation
Apico-coroal position
At least 36 months of function - at the moment of the evaluation
Inter-implant distances (IID)
Time Frame: At least 36 months of function - at the moment of the evaluation
Inter-implant distance
At least 36 months of function - at the moment of the evaluation
Implant placement protocol
Time Frame: At least 36 months of function - at the moment of the evaluation
Moment of the implant placement
At least 36 months of function - at the moment of the evaluation
Bone grafting procedures (BGP) at implant placement
Time Frame: At least 36 months of function - at the moment of the evaluation
Bone grafting associated with the implant placement
At least 36 months of function - at the moment of the evaluation
Implant-supported restorations
Time Frame: At least 36 months of function - at the moment of the evaluation
Screwed or Cemented
At least 36 months of function - at the moment of the evaluation
Cleansability of the prosthesis
Time Frame: At least 36 months of function - at the moment of the evaluation
Cleansable, difficult or impossible to clean
At least 36 months of function - at the moment of the evaluation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Cristina V Vallès, PhD, Department of Periodontology, University Internacional de Cataluña

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 5, 2024

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

January 31, 2024

First Submitted That Met QC Criteria

April 10, 2024

First Posted (Estimated)

April 15, 2024

Study Record Updates

Last Update Posted (Estimated)

April 15, 2024

Last Update Submitted That Met QC Criteria

April 10, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peri-Implantitis

3
Subscribe